Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas | BMC Cancer | Full Text

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas | BMC Cancer | Full Text

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas

The prognosis of patients with progressive or recurrent high-grade gliomas (HGGs) after surgery remains poor. Iodine-125 brachytherapy is emerging as a salvage method for the treatment of gliomas. This study a...

Authors:Congxiao Wang, Shifeng Liu, Lijing Peng, Kaixian Zhang, Wei Li, Hao Zhang, Ying Luan, Peishun Li and Xiaokun Hu

Citation:BMC Cancer 2020 20:591

Content type:Research article

 

Published on: 24 June 2020

• ViewFull Text
 
• ViewPDF